Willis Towers Watson (WLTW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Proxy statement filed for annual meeting, outlining key proposals and governance matters.
Voting matters and shareholder proposals
Shareholders are asked to vote on director elections, executive compensation, and auditor ratification.
Board of directors and corporate governance
Details provided on board composition and governance practices to ensure effective oversight.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Willis Towers Watson
- Organic growth and margin expansion drove strong results despite divestiture impacts.WLTW
Q4 20253 Feb 2026 - Q2 2024 delivered 6% organic growth, margin expansion, and raised 2024 guidance.WLTWQ2 20242 Feb 2026
- Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WLTWQ3 202417 Jan 2026
- Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WLTWCMD 202412 Jan 2026
- 5% organic growth, margin gains, $473M savings, and $1.5B buyback planned for 2025.WLTWQ4 20248 Jan 2026
- $1.3B acquisition leverages advanced tech and talent for $35M in synergies and U.S. growth.WLTWM&A Announcement10 Dec 2025
- 2025 AGM to vote on directors, auditors, executive pay, share issuance, and pre-emption rights.WLTWProxy Filing1 Dec 2025
- 5% organic growth and margin expansion offset TRANZACT sale; net income up 23%.WLTWQ1 20251 Dec 2025
- Q2 2025 saw 5% organic growth, 20% EPS rise, and robust margin expansion amid strong segment results.WLTWQ2 20255 Nov 2025